FDA Guidance Makes Vinpocetine Compliant Despite Ban Proposal – NPA

 
• By Malcolm Spicer

NPA CEO Daniel Fabricant says some vinpocetine product marketers don't realize the ingredient's status as an active moiety of a botanical long used in the food supply, a knowledge gap obscures that FDA is using an extra-regulatory procedure to remove vinpocetine.

Vinpocetine meets FDA's criteria for a compliant moiety of a botanical stated in the agency's draft guidance for new dietary ingredient notifications, another reason it should remain available in dietary supplements, according to the Natural Products Association.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America